These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 24753544)
1. Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies. Knipe DW; Evans DM; Kemp JP; Eeles R; Easton DF; Kote-Jarai Z; Al Olama AA; Benlloch S; Donovan JL; Hamdy FC; Neal DE; Smith GD; Lathrop M; Martin RM Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1356-1365. PubMed ID: 24753544 [TBL] [Abstract][Full Text] [Related]
2. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies. Kim S; Shin C; Jee SH Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496 [TBL] [Abstract][Full Text] [Related]
3. Replication study of 34 common SNPs associated with prostate cancer in the Romanian population. Jinga V; Csiki IE; Manolescu A; Iordache P; Mates IN; Radavoi D; Rascu S; Badescu D; Badea P; Mates D J Cell Mol Med; 2016 Apr; 20(4):594-600. PubMed ID: 26773531 [TBL] [Abstract][Full Text] [Related]
5. Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy. Gilbert R; Martin RM; Evans DM; Tilling K; Davey Smith G; Kemp JP; Lane JA; Hamdy FC; Neal DE; Donovan JL; Metcalfe C PLoS One; 2015; 10(10):e0136735. PubMed ID: 26431041 [TBL] [Abstract][Full Text] [Related]
6. Validation of association of genetic variants at 10q with prostate-specific antigen (PSA) levels in men at high risk for prostate cancer. Chang BL; Hughes L; Chen DY; Gross L; Ruth K; Giri VN BJU Int; 2014 May; 113(5b):E150-6. PubMed ID: 23937305 [TBL] [Abstract][Full Text] [Related]
7. The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients. He Y; Gu J; Strom S; Logothetis CJ; Kim J; Wu X Clin Cancer Res; 2014 Oct; 20(19):5133-5139. PubMed ID: 25274378 [TBL] [Abstract][Full Text] [Related]
8. Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study. Hishida A; Nakatochi M; Tamura T; Nagayoshi M; Okada R; Kubo Y; Tsukamoto M; Kadomatsu Y; Suzuki S; Nishiyama T; Kuriyama N; Watanabe I; Takezaki T; Nishimoto D; Kuriki K; Arisawa K; Katsuura-Kamano S; Mikami H; Kusakabe M; Oze I; Koyanagi YN; Nakamura Y; Kadota A; Shimanoe C; Tanaka K; Ikezaki H; Murata M; Kubo M; Momozawa Y; Takeuchi K; Wakai K; Nagoya J Med Sci; 2021 Feb; 83(1):183-194. PubMed ID: 33727749 [TBL] [Abstract][Full Text] [Related]
9. Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer. Wiklund F; Zheng SL; Sun J; Adami HO; Lilja H; Hsu FC; Stattin P; Adolfsson J; Cramer SD; Duggan D; Carpten JD; Chang BL; Isaacs WB; Grönberg H; Xu J Prostate; 2009 Mar; 69(4):419-27. PubMed ID: 19116992 [TBL] [Abstract][Full Text] [Related]
10. Genome-wide association study identified novel genetic variant on SLC45A3 gene associated with serum levels prostate-specific antigen (PSA) in a Chinese population. Sun J; Tao S; Gao Y; Peng T; Tan A; Zhang H; Yang X; Qin X; Hu Y; Feng J; Kim ST; Lin X; Wu Y; Zhang J; Li Z; Li L; Mo L; Liang Z; Shi D; Huang Z; Huang X; Liu M; Liu Q; Zhang S; Lilly Zheng S; Xu J; Mo Z Hum Genet; 2013 Apr; 132(4):423-9. PubMed ID: 23269536 [TBL] [Abstract][Full Text] [Related]
11. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection. Hughes L; Zhu F; Ross E; Gross L; Uzzo RG; Chen DY; Viterbo R; Rebbeck TR; Giri VN Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):53-60. PubMed ID: 22144497 [TBL] [Abstract][Full Text] [Related]
12. Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels. Parikh H; Wang Z; Pettigrew KA; Jia J; Daugherty S; Yeager M; Jacobs KB; Hutchinson A; Burdett L; Cullen M; Qi L; Boland J; Collins I; Albert TJ; Vatten LJ; Hveem K; Njølstad I; Cancel-Tassin G; Cussenot O; Valeri A; Virtamo J; Thun MJ; Feigelson HS; Diver WR; Chatterjee N; Thomas G; Albanes D; Chanock SJ; Hunter DJ; Hoover R; Hayes RB; Berndt SI; Sampson J; Amundadottir L Hum Genet; 2011 Jun; 129(6):675-85. PubMed ID: 21318478 [TBL] [Abstract][Full Text] [Related]
13. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA. Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173 [TBL] [Abstract][Full Text] [Related]
14. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients. Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657 [TBL] [Abstract][Full Text] [Related]
15. Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population. Beikzadeh B; Angaji SA; Abolhasani M BMC Med Genet; 2020 Apr; 21(1):81. PubMed ID: 32295536 [TBL] [Abstract][Full Text] [Related]
16. Association of gene polymorphisms of KLK3 and prostate cancer: A meta-analysis. Li H; Fei X; Shen Y; Wu Z Adv Clin Exp Med; 2020 Aug; 29(8):1001-1009. PubMed ID: 32869960 [TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism and prostate cancer aggressiveness: a case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans. Bensen JT; Xu Z; Smith GJ; Mohler JL; Fontham ET; Taylor JA Prostate; 2013 Jan; 73(1):11-22. PubMed ID: 22549899 [TBL] [Abstract][Full Text] [Related]
18. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. Lindstrom S; Schumacher F; Siddiq A; Travis RC; Campa D; Berndt SI; Diver WR; Severi G; Allen N; Andriole G; Bueno-de-Mesquita B; Chanock SJ; Crawford D; Gaziano JM; Giles GG; Giovannucci E; Guo C; Haiman CA; Hayes RB; Halkjaer J; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Navarro C; Riboli E; Sacerdote C; Stampfer M; Stram DO; Thun MJ; Trichopoulos D; Virtamo J; Weinstein SJ; Yeager M; Henderson B; Ma J; Le Marchand L; Albanes D; Kraft P PLoS One; 2011 Feb; 6(2):e17142. PubMed ID: 21390317 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide association study identifies loci at ATF7IP and KLK2 associated with percentage of circulating free PSA. Jin G; Zheng SL; Lilja H; Kim ST; Tao S; Gao Z; Young T; Wiklund F; Feng J; Isaacs WB; Rittmaster RS; Gronberg H; Condreay LD; Sun J; Xu J Neoplasia; 2013 Jan; 15(1):95-101. PubMed ID: 23359319 [TBL] [Abstract][Full Text] [Related]
20. Genome-wide association study identifies novel single nucleotide polymorphisms having age-specific effect on prostate-specific antigen levels. Li W; Bicak M; Sjoberg DD; Vertosick E; Dahlin A; Melander O; Ulmert D; Lilja H; Klein RJ Prostate; 2020 Dec; 80(16):1405-1412. PubMed ID: 32914890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]